Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence.

Drug and Alcohol Review
Llewellyn MillsKristie Mammen

Abstract

The Australian Treatment Outcomes Profile (ATOP) was developed as a clinical tool for monitoring the substance use, health and wellbeing of clients in alcohol and other drug treatment. This is the first psychometric validation of the ATOP in a cannabis-dependent treatment population. A total of 128 individuals with cannabis dependence enrolled in an outpatient randomised controlled trial were administered the ATOP and gold-standard health and wellbeing questionnaires once by clinicians and once by researchers at baseline. Concurrent validity was assessed by testing ATOP Psychological Health, Physical Health and Quality of Life questions against concurrently administered gold-standard questionnaires: the Short Form 36 Health Survey (SF-36), the 21-item Depression, Anxiety and Stress Scale (DASS-21) and the Sheehan Disability Scale (SDS). Interrater reliability was tested by comparing clinician-administered ATOP items at the medical screening interview to the same ATOP items administered by researchers at baseline. ATOP Psychological Health showed moderate to strong correlations with SF-36 Mental Components, SF-36 Mental Health and DASS-21 scores (r = 0.40-0.52) and ATOP Physical Health with SF-36 Physical Components and SF-36 Ge...Continue Reading

References

Mar 1, 1992·Social Psychiatry and Psychiatric Epidemiology·A C LeonG L Klerman
Jun 1, 1996·International Clinical Psychopharmacology·D V SheehanB A Raj
Jan 1, 1997·Behaviour Research and Therapy·T A BrownD H Barlow
Dec 16, 1998·The American Journal of Drug and Alcohol Abuse·J B DaeppenB Yersin
Jan 5, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·J E Ware, M Kosinski
Mar 27, 2002·Psychosomatic Medicine·Kurt KroenkeJanet B W Williams
Apr 10, 2002·Journal of Health Economics·John BrazierMark Deverill
Jun 28, 2003·The British Journal of Clinical Psychology·John R Crawford, Julie D Henry
Jul 27, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Knut StavemKjell B Hellum
Sep 12, 2008·Addiction·John MarsdenSteve Taylor
Dec 2, 2008·Psychiatry Research·Robert ArbuckleAlessio Degl' Innocenti
Oct 6, 2009·Lancet·John MarsdenUNKNOWN National Drug Treatment Monitoring System Outcomes Study Group
Aug 13, 2011·Substance Use & Misuse·Shiyan YanZhimin Liu
Jun 14, 2012·Addiction·John MarsdenUNKNOWN National Drug Treatment Monitoring System Outcomes Study Group
Apr 2, 2014·Journal of the Formosan Medical Association = Taiwan Yi Zhi·En-Chi ChiuChing-Lin Hsieh
Apr 16, 2014·Drug and Alcohol Dependence·John MarsdenEdward Day
May 29, 2014·Australian Journal of Primary Health·Michael SavicDan I Lubman
Jun 6, 2014·Neuropsychiatric Disease and Treatment·Theresa ColesAri Gnanasakthy
Apr 11, 2015·Journal of Substance Abuse Treatment·Álvaro Castillo-CarnigliaRodrigo Portilla Huidobro
Sep 13, 2015·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Glenys DoreRobin Murray
Jan 29, 2016·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·S Fiona BarkerBrian Rush
May 20, 2018·BMC Psychiatry·Anjali K BhardwajUNKNOWN Agonist Replacement for Cannabis Dependence (ARCD) study group
Jul 16, 2019·JAMA Internal Medicine·Nicholas LintzerisUNKNOWN Agonist Replacement for Cannabis Dependence (ARCD) study group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.